Download


Ultra Thyroid Stimulating Hormone (TSH)
Investigation Result Units Biological Reference Interval

ULTRA Thyroid Stimulating Hormone (TSH) 2.2 uIU/mL 0.27 - 4.2
Frist trimester: 0.3- 4.5
Second trimester : 0.5 -4.6
Third trimester : 0.8 -5.2
• Sample Type : Serum.
• Method : ECLIA.

• Comments : - TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm . - The variation is of the order of 50% , hence time of the day has influence on the measured serum TSH concentrations. • Clinical Use : - Diagnose Hypothyroidism and Hyperthyroidism. - Monitor T4 replacement or T4 suppressive therapy. - Quanitify TSH levels in the subnormal range. • Increased Levels : Primary hypothyroidism, Subclinical hypothyroidism, TSH dependent Hyperthyroidism Thyroid hormone resistance. • Decreased Levels : Graves disease, Autonomous thyroid hormone secretion, TSH deficiency. • References : - Henry’s Clinical Diagnosis and Management, 23rd edition. - Tietz Fundamentals of Clinical Chemistry and Molecular Diagnosis, 7th edition. •Disclaimer: 1) The above result relate only to the specimens received and tested in laboratory and should be always correlate with clinicalfindings and other laboratory markers. 2) Improper specimen collection, handling,storage and transportation may result in false negative/Positive results.

--End Of Report--
Beta HCG
Investigation Result Units Biological Reference Interval

Beta HCG 3.06 mIU/mL Non Pregnant: < 5

• Sample Type: Serum. • Method: ECLIA. • Weeks Of Gestation HCG : Week Range | Week Range 3 Weeks 5.40 - 72.0 | 10 Weeks 44186-170409 4 Weeks 50 - 708 | 12 Weeks 27107 -201615 5 Weeks 217 - 8245 | 14 Weeks 24302 - 93646 6 Weeks 152 - 32177 | 15 Weeks 12540 - 69747 7 Weeks 4059 - 153767 | 16 Weeks 8904 - 55332 8 Weeks 31366 - 149094 | 17 Weeks 8240 - 51793 9 Weeks 59109-135901 | 18 Weeks 9649 - 55271 • Note : This test is not recommended to screen Germ cell tumors in the general population. HCG levels may appear consistently elevated / depressed due to the interference by heterophilic antibodies, nonspecific protein binding, HCG like substances & certain medications • Clinical Use : 1. An aid in the management of Trophoblastic tumors. HCG is elevated in nearly all patients and correlates with tumor volume and disease prognosis. It is also useful in monitoring therapy. Persistent HCG levels following therapy indicate the presence of residual disease. During chemotherapy, weekly HCG measurement is recommended. After remission is achieved, yearly HCG measurement is recommended to detect relapse. 2. Monitoring Germ cell tumors, Non seminomatous testicular tumors & less frequently Seminomas. HCG alone is useful in identifying Trophoblastic tumors, and alongwith AFP in detecting Non seminomatous testicular tumors. • Increased Levels are seen in Testicular tumors , Ovarian Germ cell tumors, Gestational Trophoblastic disease, Non germ cell tumors – Melanoma & Carcinomas of breast, GI Tract, Lung & Ovary.b Benign conditions like Cirrhosis, Duodenal ulcer and Inflammatory bowel disease. • Disclaimer : 1) The above result relate only to the specimens received and tested in laboratory and should be always correlate with clinical findings and other laboratory markers. 2) Improper specimen collection, handling,storage and transportation may result in false negative/Positive results.

--End Of Report--